SkinBioTherapeutics Plc

SBTX.L · LSE
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-£1-£3-£3-£3
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0-£0-£0
Stock-Based Comp.£0£0£0£0
Change in WC-£1-£0£0£0
Other Non-Cash-£0£0£0-£0
Operating Cash Flow-£1-£3-£3-£3
Investing Activities
PP&E Inv.-£0-£0-£0-£0
Net Acquisitions-£1-£2£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.£0-£1-£0£0
Investing Cash Flow-£2-£2-£0-£0
Financing Activities
Debt Repay.£1£1-£0-£0
Stock Issued£6£3£2£0
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£0-£0£0£0
Financing Cash Flow£7£5£2-£0
Forex Effect£0£0£0£0
Net Chg. in Cash£4-£1-£0-£3
Supplemental Information
Beg. Cash£1£1£2£5
End Cash£5£1£1£2
Free Cash Flow-£1-£3-£3-£3
SkinBioTherapeutics Plc (SBTX.L) Financial Statements & Key Stats | AlphaPilot